Recursion Pharmaceuticals Puts Strength on Full Display [TheStreet.com]
Recursion Pharmaceuticals, Inc. - Class A (RXRX)
Company Research
Source: TheStreet.com
The strongest companies can raise money in any environment.Recursion Pharmaceuticals(RXRXThe new capital will pad abalance sheetIt's also a promising sign of strength for investors, although long-term performance will be driven by execution and clinical trial data.Mapping Biology to Discover New DrugsRecursion Pharmaceuticals is a technology-enabled drug developer. It's part of an emerging field that utilizes supercomputers, machine learning, and automated robotic labs to conduct discovery-stage R&D within the context of drug development. The idea is that the combination of such tools can enable scientists to evaluate chemical compounds with drug-like potential on much larger scales and much quicker timelines than with traditional chemistry and biology approaches.Each company in the field has a slightly different approach. Recursion Pharmaceuticals is building maps of biology to understand how genes interact with one another and their role in disease. The company's scientists perform
Show less
Read more
Impact Snapshot
Event Time:
RXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXRX alerts
High impacting Recursion Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RXRX
News
- Recursion to Participate in Upcoming Investor ConferencesGlobeNewswire
- Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering ProgramGlobeNewswire
- Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves [Yahoo! Finance]Yahoo! Finance
- Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
RXRX
Earnings
- 2/27/24 - Beat
RXRX
Sec Filings
- 5/1/24 - Form 144
- 4/30/24 - Form 144
- 4/29/24 - Form 4
- RXRX's page on the SEC website